How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Stereotactic Radiation Therapy Linear Particle Accelerator Market
- By Technology Type: Gamma Knife, CyberKnife, TrueBeam, Edge Radiosurgery System, Halcyon System
- By Application: Brain Tumors, Spinal Tumors, Lung Cancer, Prostate Cancer, Liver Cancer
- By End User: Hospitals, Specialty Cancer Clinics, Ambulatory Surgical Centers, Research Institutes
- By Treatment Modality: Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Fractionated Stereotactic Radiotherapy (FSRT)
- By Linear Accelerator Type: Conventional LINAC, Image-Guided LINAC (IGRT), Intensity-Modulated Radiation Therapy LINAC (IMRT)
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Gamma Knife leads By Technology Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 286 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.178 →
- 12 Company Profiles 12 players: SWOT & benchmarking p.186 →
Full report · locked preview
Everything inside the Stereotactic Radiation Therapy Linear Particle Accelerator Market report
A complete, evidence-based study - 12 chapters and 120 sections covering market size, segmentation across 5 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Technology Type 5
Application 5
End User 4
Treatment Modality 3
Linear Accelerator Type 3
Companies profiled
Varian Medical Systems (a Siemens Healthineers company)
Elekta AB
Accuray Incorporated
IBA (Ion Beam Applications)
Mevion Medical Systems
ViewRay Inc.
Brainlab AG
Siemens Healthineers
Canon Medical Systems Corporation
Hitachi Ltd.
Toshiba Medical Systems Corporation
Mitsubishi Electric Corporation
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Varian Medical Systems (a Siemens Healthineers company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Elekta AB
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Accuray Incorporated
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →IBA (Ion Beam Applications)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Mevion Medical Systems
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →ViewRay Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Brainlab AG
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Siemens Healthineers
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Canon Medical Systems Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Hitachi Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Toshiba Medical Systems Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Mitsubishi Electric Corporation
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,035M by 2033 · 10.9% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Gamma Knife53.7
- CyberKnife15.0
- TrueBeam14.3
- Edge Radiosurgery System9.5
- Halcyon System7.6
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$149.4M → $367.3M · 11.9%
Europe$104.1M → $214.7M · 9.5%
Asia Pacific$95.1M → $197.5M · 9.6%
Latin America$58.9M → $149.2M · 12.3%
Middle East and Africa$45.3M → $93.1M · 9.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.832026
10.862027
10.872028
10.872029
10.892030
10.902031
10.922032
10.932033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Varian Medical Systems (a Siemens Healthineers company)22.4
- Elekta AB17.4
- Accuray Incorporated9.5
- IBA (Ion Beam Applications)9.9
- Mevion Medical Systems7.1
- ViewRay Inc.5.7
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Technology Type19.0%
Application10.6%
End User31.4%
Treatment Modality22.0%
Linear Accelerator Type16.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America35.9
- Europe21.0
- Asia Pacific19.3
- Latin America14.6
- Middle East and Africa9.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Varian Medical Systems (a Siemens Healthineers company) | 80 | 81 | 73 | 74 | 97 | 75 | 80 |
| Elekta AB | 76 | 69 | 80 | 68 | 77 | 72 | 74 |
| Accuray Incorporated | 66 | 87 | 87 | 75 | 86 | 87 | 81 |
| IBA (Ion Beam Applications) | 79 | 76 | 76 | 64 | 65 | 66 | 71 |
| Mevion Medical Systems | 75 | 52 | 71 | 73 | 66 | 66 | 67 |
| ViewRay Inc. | 67 | 67 | 64 | 58 | 51 | 51 | 60 |
| Brainlab AG | 43 | 61 | 41 | 54 | 47 | 43 | 48 |
| Siemens Healthineers | 58 | 53 | 49 | 51 | 51 | 48 | 52 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Varian Medical Systems (a Siemens Healthineers company)
- Elekta AB
- Accuray Incorporated
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Varian Medical Systems (a Siemens Healthineers company) | ◐ | ◐ | ◐ | − | ◐ | ✓ |
| Elekta AB | − | ◐ | ◐ | − | ✓ | ◐ |
| Accuray Incorporated | ◐ | ✓ | ✓ | ✓ | ✓ | ◐ |
| IBA (Ion Beam Applications) | ◐ | ◐ | ✓ | − | ◐ | ✓ |
| Mevion Medical Systems | ✓ | − | ◐ | ◐ | ◐ | ◐ |
| ViewRay Inc. | ◐ | − | ◐ | ◐ | − | ◐ |
| Brainlab AG | − | − | − | − | ◐ | − |
| Siemens Healthineers | − | − | − | − | ◐ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Accuray Incorporated81
2Varian Medical Systems (a Siemens Healthineers company)80
3Elekta AB74
4IBA (Ion Beam Applications)71
5Mevion Medical Systems67
6ViewRay Inc.60
7Siemens Healthineers52
8Brainlab AG48
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Varian Medical Systems (a Siemens Healthineers company)Accuray Incorporated
Challenger3
Strong scale, closing on the leaders.
Elekta ABIBA (Ion Beam Applications)Mevion Medical Systems
Contender1
Focused players with pockets of strength.
ViewRay Inc.
Niche2
Specialists in a single segment or region.
Brainlab AGSiemens Healthineers
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Technology Type in North America, then scale across Stereotactic Radiation Therapy Linear Particle Accelerator Market — a $481M beachhead inside a $7.41B market.
Beachhead (SOM)$481Mobtainable near-term
Serviceable (SAM)$2.58Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion91 fit
Gamma Knife
Best fit — highest urgency & budget in Technology Type.
Economic buyer79 fit
CyberKnife
Strong fit — clear ROI and a fast path to value.
End user70 fit
TrueBeam
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Technology Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel26%
Digital / self-serve23%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Technology Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Stereotactic Radiation Therapy Linear Particle Accelerator Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified25%
Evaluation12%
Closed-won6%
$10.5KCAC
$45KLTV
4.3:1LTV : CAC
< 5 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Stereotactic Radiation Therapy Linear Particle Accelerator Market is a high-growth opportunity — $6.62B by 2033, compounding at 11.1%.
TAM · 2025$2.85Btoday
TAM · 2033$6.62Bforecast
CAGR11.1%2027–2033
Cumulative$40.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.62BTotal addressable market
SAM$2.37BServiceable available market
SOM$483MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.1% CAGR
Demand compounds through 2033, outpacing GDP across Technology Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Technology Type moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.62BLarge & growingTAM by 2033 at 11.1% CAGR
$2.37BServiceable nowreachable with today’s model
$483MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.17BBear7.2% CAGR
$6.62BBase11.1% CAGR
$8.48BBull14.7% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Stereotactic Radiation Therapy Linear Particle Accelerator Market — a $3.65B market by 2033. Plan: grow share from 7.3% to 13.2%.
Market size · 2033$3.65Btotal addressable
Market CAGR9.1%2027–2033
Target share13.2%from 7.3% today
Revenue ambition$481Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 7.3% | 13.2% | On track |
| Revenue | $284M | $481M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Ahead |
| Gross margin | 31.1% | 38.9% | At risk |
| Customer retention | 88.2% | 96.1% | On track |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Technology Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Technology Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $60M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Technology Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Stereotactic Radiation Therapy Linear Particle Accelerator Market conversation — a $1.97B market you can size, segment and defend in minutes.
Market size · 2033$1.97Btotal opportunity
Growth7.0%CAGR to 2033
Addressable buyers1,654+accounts in scope
Typical ROI5×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Technology Type
Goal Grow share in Technology Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5×return on cost, year one
< 3 mopayback period
$59K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Varian Medical Systems (a Siemens Healthineers company)Elekta ABAccuray IncorporatedIBA (Ion Beam Applications)Mevion Medical SystemsViewRay Inc.Brainlab AGSiemens Healthineers+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Stereotactic Radiation Therapy Linear Particle Accelerator Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Stereotactic Radiation Therapy Linear Particle Accelerator Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Stereotactic Planning Software Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportStereotactic Frame for Veterinary Market
Market size, share, segmentation and regional forecast.
$2.0B market · 2025 base year
View reportStereotactic Breast Biopsy System Market
Market size, share, segmentation and regional forecast.
$1.4B market · 2025 base year
View reportStereoscopic Optical Microscopes Market
Market size, share, segmentation and regional forecast.
$4.6B market · 2025 base year
View reportStereo Microscopes Market
Market size, share, segmentation and regional forecast.
$2.2B market · 2025 base year
View reportStereo Colposcopy Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportStepper Pipettes Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportStephania Extract Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportStent Test Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportStent Retriever Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportStentless Bioprostheses Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportStent Grafts Market
Market size, share, segmentation and regional forecast.
$1.9B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.